Б 249
Каталог "Библиографии" | Списание
Palliative radiotherapy in patients with multiple myeloma
Mariana P. Yaneva; Veselina St. Goranova-Marinova; Stefan E. Goranov
A 512
A 512
Каталог "Библиографии" | Списание
Kappa and Lambda light chain proteins - clinical and prognostic significance in patients with multiple myeloma
St. Goranov
A 512
Каталог "Библиографии" | Списание
Prognostic assessment of the durie and salmon staging system in patients with multiple myeloma
E. Spasov; V. Goranova
A 512
Каталог "Библиографии" | Списание
Osteonecrosis of the jaw in patients on bisphosphonate treatment. Review of literature with contribution of a case of multiple myeloma
Vesselina S. Goranova-Marinova; Petya F. Pechalova-Petrova; Stefan G. Goranov
Каталог "Библиографии" | Списание
Serum levels of OPG and RANKL/OPG ratios in newly-diagnosed patients with multiple myeloma. Clinical correlations
V. Goranova-Marinova; S. Goranov; P. Pavlov;
T. Tzvetkova
и др.
Каталог "Библиографии" | Списание
Comparative analisys of the staging systems of Durie&Salmon and International Staging System(ISS) in patients with multiple myeloma
V. Goranova-Marinova; P. Georgiev; K. Sotirova;
E. Spasov;
I. Hristova;
M. Dimitrova;
K. Sapunarova
и др.
A 512
Каталог "Библиографии" | Списание
Clinical problems of infectious complications in patients with multiple myeloma
S. Goranov
A 512
Каталог "Библиографии" | Списание
Hipercalcaemia and azotaemia in mutiple myeloma - clinical and biochemical parallels
S. Goranov
A 512
Каталог "Библиографии" | Списание
Nephrogenic diabetes insipidus - prodromal phase of multiple myeloma
S. Goranov; I. Hristova; K. Pencheva
Каталог "Библиографии" | Списание
Therapeutic response in patients with macrofocal form of multiple myeloma, treated with bortezomib-containing regimens
V. Goranova-Marinova; A. Nedeva; P. Georgiev;
I. Hristova;
R. Stanchev;
J. Rajnov;
St. Goranov
и др.
Каталог "Библиографии" | Списание
The pathogenetic interrelations between bone and renal damages in patients with multiple myeloma are of a "vicious circle" type
S. Goranov; V. Goranova-Marinova
Каталог "Библиографии" | Списание
Reversal of the renal failure after therapy with bortezomib in patients with multiple myeloma
A. Nedeva; V. Goranova-Marinova; P. Georgiev;
I. Hristova;
J. Raynov;
S. Goranov;
I. Gigov;
I. Nikolov
и др.
Каталог "Библиографии" | Списание
Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: Results from optimum, a randomized trial
M. Kropff; S. Goranov; H. Baylon
A 1454
Каталог "Библиографии" | Списание
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
Keith A. Stewart; Vincent S. Rajkumar; Meletios A. Dimopoulos;
Tamas Masszi;
Ivan Spicka;
Albert Oriol;
Georgi Mihaylov;
Vesselina Goranova-Marinova
и др.
Каталог "Библиографии" | Списание
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma
H. Avet-Loiseau; V. Goranova-Marinova; et al.
Каталог "Библиографии" | Списание
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Meletios A. Dimopoulos; V. Goranova-Marinova; et al.
Б 335
Каталог "Библиографии" | Списание
Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial
Martin Kropff; Stefan Goranov; et al.
A 590
Каталог "Библиографии" | Списание
Multiple myeloma with advanced bone disease and low tumor burden - different clinical presentation but similar outcome after bortezomib-based therapy and radiotherapy
Vesselina Goranova-Marinova; Marianna Yaneva; Tanya Deneva;
Stefan Goranov
и др.
Каталог "Библиографии" | Списание
Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup
H. Ludwig; V. Goranova-Marinova; et al.